Ribonuclease inhibitor as an intracellular sentry

Nucleic Acids Research

Volumn 31, Issue 3, 2003, Pages 1024-1032

  Haigis, Marcia C ^a,c   Kurten, Erin L ^a   Raines, Ronald T ^a,b  

^a Department of Biochemistry ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; RANPIRNASE; RIBONUCLEASE; RIBONUCLEASE A; RIBONUCLEASE INHIBITOR; RNA; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CELL GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; RNA DEGRADATION;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CELLS, CULTURED; HUMANS; INHIBITORY CONCENTRATION 50; MICROSCOPY, FLUORESCENCE; NEOPLASMS; PROTEINS; RECOMBINANT FUSION PROTEINS; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037324378     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg163     Document Type: Review

References (66)

1. Raines,R.T. (1998) Ribonuclease A. Chem. Rev., 98, 1045-1065.
2. Raines,R.T. (1999) Ribonuclease A: from model system to cancer chemotherapeutic. In Frey,P.A. and Northrop,D.B. (eds), Enzymatic Mechanisms. IOS Press, Washington, DC, pp. 235-249.
3. D'Alessio,G. (1993) New and cryptic biological messages from RNases. Trends Cell Biol., 3, 106-109.
4. Schein,C.H. (1997) From housekeeper to microsurgeon: the diagnostic and therapeutic potential of ribonucleases. Nat. Biotechnol., 15, 529-536.
5. Leland,P.A. and Raines,R.T. (2001) Cancer chemotherapy - ribonucleases to the rescue. Chem. Biol., 8, 405-413.
6. Rybak,S.M. and Newton,D.L. (1999) Natural and engineered cytotoxic ribonucleases: therapeutic potential. Exp. Cell Res., 253, 325-335.
7. Matousek,J. (2001) Ribonucleases and their antitumor activity. Comp. Biochem. Physiol., 129C, 175-191.
8. Matousek,J. (1973) The effect of bovine seminal ribonuclease (AS RNase) on cells of crocker tumour in mice. Experientia, 29, 858-859.
9. Matousek,J. (1975) Embryotoxic effect of bull seminal ribonuclease and tissue absorption studies in rats. J. Reprod. Fertil., 43, 171-174.
10. Dostál,J. and Matousek,J. (1972) Purification of aspermatogenic substance (AS) from the bull seminal vesicle fluid. J. Reprod. Fertil., 31, 273-275.
11. Matousek,J. (1994) Aspermatogenic effect of the bull seminal ribonuclease (BS RNase) in the presence of anti BS RNase antibodies in mice. Anim. Genet., 25 (suppl. 1), 45-50.
12. Slavik,T., Matousek,J., Fulka,J. and Raines,R.T. (2000) Effect of bovine seminal ribonuclease and bovine pancreatic ribonuclease A on bovine oocyte maturation. J. Exp. Zool., 287, 394-399.
13. Darzynkiewicz,Z., Carter,S.P., Mikulski,S.M., Ardelt,W.J. and Shogen,K. (1988) Cytostatic and cytotoxic effect of Pannon (P-30 protein), a novel anticancer agent. Cell Tissue Kinet., 21, 169-182.
14. Youle,R.J. and D'Alessio,G. (1997) Antitumor RNases. In D'Alessio,G. and Riordan,J.F. (eds), Ribonucleases: Structures and Functions. Academic Press, New York, NY, pp. 491-514.
15. Vasandani,V.M., Wu,Y.-N., Mikulski,S.M., Youle,R.J. and Sung,C. (1996) Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily. Cancer Res., 56, 4180-4186.
16. Juan,G., Ardelt,B., Li,X., Mikulski,S.M., Shogen,K., Ardelt,W., Mittelman,A. and Darzynkiewicz,Z. (1998) G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation. Leukemia, 12, 1241-1248.
17. Ledoux,L. (1955) Action of ribonuclease on certain ascites tumours. Nature, 175, 258-259.
18. Ledoux,L. (1955) Action of ribonuclease on two solid tumours in vivo. Nature, 176, 36-37.
19. Leland,P.A., Schultz,L.W., Kim,B.-M. and Raines,R.T. (1998) Ribonuclease A variants with potent cytotoxic activity. Proc. Natl Acad. Sci. USA, 98, 10407-10412.
20. Haigis,M.C., Kurten,E.L. and Raines,R.T. (2002) KFERQ sequence in ribonuclease A-mediated cytotoxicity. J. Biol. Chem., 277, 11576-11581.
21. Lee,F.S. and Vallee,B.L. (1993) Structure and action of mammalian ribonuclease (angiogenin) inhibitor. Prog. Nucleic Acid Res. Mol. Biol., 44, 1-30.
22. Hofsteenge,J. (1997) Ribonuclease inhibitor. In D'Alessio,G. and Riordan,J.F. (eds), Ribonucleases: Structures and Functions. Academic Press, New York, NY, pp. 621-658.
23. Shapiro,R. (2001) Cytoplasmic ribonuclease inhibitor. Methods Enzymol., 341, 611-628.
24. Kobe,B. and Deisenhofer,J. (1995) A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature, 374, 183-186.
25. Lee,F.S., Shapiro,R. and Vallee,B.L. (1989) Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry, 28, 225-230.
26. Vicentini,A.M., Kieffer,B., Mathies,R., Meyhack,B., Hemmings,B.A., Stone,S.R. and Hofsteenge,J. (1990) Protein chemical and kinetic characterization of recombinant porcine ribonuclease inhibitor expressed in Saccharomyces cerevisiae. Biochemistry, 29, 8827-8834.
27. Boix,E., Wu,Y., Vasandani,V.M., Saxena,S.K., Ardelt,W., Ladner,J. and Youle,R.J. (1996) Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity. J. Mol. Biol., 257, 992-1007.
28. Bretscher,L.E., Abel,R.L. and Raines,R.T. (2000) A ribonuclease A variant with low catalytic activity but high cytotoxicity. J. Biol. Chem., 275, 9893-9896.
29. del Cardayré,S.B., Ribó,M., Yokel,E.M., Quirk,D.J., Rutter,W.J. and Raines,R.T. (1995) Engineering ribonuclease A: production, purification and characterization of wild-type enzyme and mutants at Gln11. Protein Eng., 8, 261-273.
30. Sela,M., Anfinsen,C.B. and Harrington,W.F. (1957) The correlation of ribonuclease activity with specific aspects of tertiary structure. Biochim. Biophys. Acta, 26, 502-512.
31. Pace,C.N., Vajdos,F., Fee,L., Grimsley,G. and Gray,T. (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci., 4, 2411-2423.
32. Segel,L.A. (1980) Mathematical Models in Molecular and Cellular Biology. Cambridge University, London, UK, pp. 502-522.
33. Malthus,T.R. (1798) An Essay on the Principle of Population, as it Affects the Future Improvement of Society, with Remarks on the Speculations of Mr. Godwin, M. Condorcet and Other Writers. Johnson, London, UK.
34. Blázquez,M., Fominaya,J.M. and Hofsteenge,J. (1996) Oxidation of sulfhydryl groups of ribonuclease inhibitor in epithelial cells is sufficient for its intracellular degradation. J. Biol. Chem., 271, 18638-18642.
35. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-252.
36. Laemmli,U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
37. Kelemen,B.R., Klink,T.A., Behlke,M.A., Eubanks,S.R., Leland,P.A. and Raines,R.T. (1999) Hypersensitive substrate for ribonucleases. Nucleic Acids Res., 27, 3696-3701.
38. Nadano,D., Yasuda,T., Takeshita,H., Uchide,K. and Kishi,K. (1994) Purification and characterization of human brain ribonuclease inhibitor. Arch. Biochem. Biophys., 312, 421-428.
39. Blackburn,P. and Moore,S. (1982) Pancreatic ribonuclease. Enzymes, XV, 317-433.
40. Heim,R., Prasher,D.C. and Tsien,R.Y. (1994) Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc. Natl Acad. Sci. USA, 91, 12501-12504.
41. Cubitt,A.B., Heim,R., Adams,S.R., Boyd,A.E., Gross,L.A. and Tsien,R.Y. (1995) Understanding, improving and using green fluorescent proteins. Trends Biochem. Sci., 20, 448-455.
42. Heim,R. and Tsien,R.Y. (1996) Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr. Biol., 6, 178-182.
43. Tsien,R.Y. (1998) The green fluorescent protein. Annu. Rev. Biochem., 67, 509-544.
44. Kobe,B. and Deisenhofer,J. (1996) Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J. Mol. Biol., 264, 1028-1043.
45. Papageorgiou,A., Shapiro,R. and Acharya,K. (1997) Molecular recognition of human angiogenin by placental ribonuclease inhibitor - an X-ray crystallographic study at 2.0 Å resolution. EMBO J., 16, 5162-5177.
46. Yang,F., Moss,L.G. and Phillips,G.N.,Jr (1996) The molecular structure of green fluorescent protein. Nat. Biotechnol., 14, 1246-1251.
47. Haigis,M.C., Haag,E.S. and Raines,R.T. (2002) Evolution of ribonuclease inhibitor by exon duplication. Mol. Biol. Evol., 19, 960-964.
48. Lin,J.J., Newton,D.L., Mikulski,S.M., Kung,H.F., Youle,R.J. and Rybak,S.M. (1994) Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease. Biochem. Biophys. Res. Commun., 204, 156-162.
49. Kojima,K. (1993) Molecular aspects of the plasma membrane in tumor cells. Nagoya J. Med. Sci., 56, 1-18.
50. Ardelt,W., Mikulski,S.M. and Shogen,K. (1991) Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. J. Biol. Chem., 266, 245-251.
51. Garcîa-Segura,J.M., Fominaya,J.M., Ferreras,M., Cid,C. and Gavilanes,J.G. (1991) On the biological function of the RNase-RNase inhibitor system. In de Llorens,R., Cuchillo,C.M., Nogués,M.V. and Parés,X. (eds), Structure, Mechanism and Function of Ribonucleases. Universitat Autónoma de Barcelona, Bellaterra, Spain, pp. 189-194.
52. Saxena,S.K., Rybak,S.M., Winkler,G., Meade,H.M., McGray,P., Youle,R.J. and Ackerman,E.J. (1991) Comparison of RNases and toxins upon injection into Xenopus oocytes. J. Biol. Chem, 266, 21208-21214.
53. Wu,Y., Saxena,S.K., Ardelt,W., Gadina,M., Mikulski,S.M., De Lorenzo,V., D'Alessio,G. and Youle,R.J. (1995) A study of the intracellular routing of cytotoxic ribonucleases. J. Biol. Chem., 270, 17476-17481.
54. Wu,Y., Mikulski,S.M., Ardelt,W., Rybak,S.M. and Youle,R.J. (1993) A cytotoxic ribonuclease. J. Biol. Chem., 268, 10686-10693.
55. Newton,D.L., Ilercil,O., Laske,D.W., Oldfield,E., Rybak,S.M. and Youle,R.J. (1992) Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo. J. Biol. Chem., 267, 19572-19578.
56. Suzuki,M., Saxena,S.K., Boix,E., Prill,R.J., Vasandani,V.M., Ladner,J.E., Sung,C. and Youle,R.J. (1999) Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction [see comments]. Nat. Biotechnol., 17, 265-270.
57. Wojnar,R.J. and Roth,J.S. (1965) Ribonuclease inhibitor and latent ribonuclease in rat liver during feeding of 2-acetamidofluorene. Cancer Res., 25, 1913-1918.
58. Suzuki,Y. and Takahashi,Y. (1970) Developmental and regional variations in ribonuclease inhibitor activity in brain. J. Neurochem., 17, 1521-1524.
59. Kyner,D., Christman,J.K. and Acs,G. (1979) The effect of 12-O-tetradecanoyl-phorbol 13-acetate on the ribonuclease activity of circulating human lymphocytes. Eur. J. Biochem., 99, 395-399.
60. Gauvreau,D., Gagnon,C. and de Lamirande,G. (1974) Purification of a ribonuclease inhibitor from Novikoff hepatoma supernatant fraction. Cancer Res., 34, 2500-2503.
61. Roth,J.S., Hilton,S. and Morris,H.P. (1964) Ribonuclease activity in some transplantable rat hepatomas. Cancer Res., 24, 294-301.
62. Botella-Estrada,R., Malet,G., Revert,F., Dasi,F., Crespo,A., Sanmartin,O., Guillen,C. and Alino,S.F. (2001) Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor rnasin. Cancer Gene Ther., 8, 278-284.
63. Futami,J., Nukui,E., Maeda,T., Kosaka,M., Tada,H., Seno,M. and Yamada,H. (2002) Optimum modification for the highest cytotoxicity of cationized ribonuclease. J. Biochem. (Tokyo), 132, 223-228.
64. Ellis,R.J. (2001) Macromolecular crowding: obvious but underappreciated. Trends Biochem. Sci., 26, 597-604.
65. Futami,J., Tsushima,Y., Murato,Y., Tada,H., Sasaki,J., Seno,M. and Yamada,H. (1997) Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biol., 16, 413-419.
66. Weickmann,J.L., Olson,E.M. and Glitz,D.G. (1984) Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer. Cancer Res., 44, 1682-1687.